Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder

@article{Popovic2012PolarityIO,
  title={Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder},
  author={D. Popovic and M. Reinares and J. Goikolea and C. Bonn{\'i}n and E. Vieta},
  journal={European Neuropsychopharmacology},
  year={2012},
  volume={22},
  pages={339-346}
}
  • D. Popovic, M. Reinares, +2 authors E. Vieta
  • Published 2012
  • Medicine, Psychology
  • European Neuropsychopharmacology
  • Over one half of bipolar patients have been reported to be more prone to either depressive or manic relapses. This study aimed to define profiles of drugs used for maintenance treatment of bipolar disorder (BD) by the means of Polarity Index. Polarity Index is a new metric indicating the relative antimanic versus antidepressive preventive efficacy of drugs. Polarity Index was retrieved by calculating Number Needed to Treat (NNT) for prevention of depression and NNT for prevention of mania ratio… CONTINUE READING
    Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry
    • 102
    Genetic Influences on Response to Mood Stabilizers in Bipolar Disorder
    • 52
    • Open Access
    Treatment Implications of Predominant Polarity and the Polarity Index: A Comprehensive Review
    • 29
    • Highly Influenced
    • Open Access
    Psychosocial interventions in bipolar disorder: what, for whom, and when.
    • 106
    Treatment of Bipolar Disorder in a Lifetime Perspective: Is Lithium Still the Best Choice?
    • 25
    • Open Access

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 46 REFERENCES
    A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
    • 537
    • Highly Influential
    A Randomized, Placebo-Controlled 12-Month Trial of Divalproex and Lithium in Treatment of Outpatients With Bipolar I Disorder
    • 597
    • Highly Influential
    • Open Access
    Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.
    • 265
    • Highly Influential
    • Open Access
    A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
    • 577
    • Highly Influential
    • Open Access
    The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.
    • 386
    • Open Access
    Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo.
    • 217
    • Highly Influential